Question 1

What does Ligand Pharmaceuticals do?

Accepted Answer

Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies.

Question 2

In what sectors does Ligand Pharmaceuticals operate?

Accepted Answer

Ligand Pharmaceuticals operates in Biotechnology, Chemical, Health Care, Medical, Pharmaceutical.

Question 3

How many companies has Ligand Pharmaceuticals acquired?

Accepted Answer

Ligand Pharmaceuticals has made 14 acquisitions between 2008-2026, with a total disclosed deal value of $1.5B.

Question 4

What companies are owned by Ligand Pharmaceuticals?

Accepted Answer

Companies acquired by Ligand Pharmaceuticals include XOMA, Apeiron Biologics, xCella Biosciences, Taurus Biosciences, Pfenex, Icagen - Core Assets, Partnered Programs And ION Channel Technologies, Ab Initio Biotherapeutics, Vernalis, and 6 more.

Question 5

What are Ligand Pharmaceuticals's major acquisitions?

Accepted Answer

Ligand Pharmaceuticals's largest acquisitions include XOMA ($739.0M, 2026), Pfenex ($438.0M, 2020), OMT ($178.0M, 2015), Apeiron Biologics ($100.0M, 2024).

Question 6

What is Ligand Pharmaceuticals's largest acquisition?

Accepted Answer

Ligand Pharmaceuticals's largest disclosed acquisition is XOMA for $739.0M (2026).

Question 7

What was Ligand Pharmaceuticals's first acquisition?

Accepted Answer

Ligand Pharmaceuticals's first recorded acquisition was Pharmacopeia in 2008.

Question 8

What was Ligand Pharmaceuticals's most recent acquisition?

Accepted Answer

Ligand Pharmaceuticals's most recent acquisition is XOMA, announced April 2026 for $739.0M.

Question 9

What is the average deal size for Ligand Pharmaceuticals acquisitions?

Accepted Answer

The average disclosed deal size for Ligand Pharmaceuticals acquisitions is $153.9M.

Question 10

What is the median deal size for Ligand Pharmaceuticals acquisitions?

Accepted Answer

The median disclosed deal size for Ligand Pharmaceuticals acquisitions is $29.0M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Ligand Pharmaceuticals spent on acquisitions?

Accepted Answer

Ligand Pharmaceuticals has spent at least $1.5B across its disclosed acquisitions (of 14 total deals; some prices are undisclosed).

Question 12

Which sector has Ligand Pharmaceuticals spent the most on?

Accepted Answer

Ligand Pharmaceuticals has committed the most disclosed capital to Biotechnology companies — about $1.3B across its deals in that sector.

Question 13

What sectors does Ligand Pharmaceuticals usually acquire in?

Accepted Answer

Ligand Pharmaceuticals most frequently acquires companies in Biotechnology, Therapeutics, Pharmaceutical.

Question 14

In which sector has Ligand Pharmaceuticals made the most acquisitions?

Accepted Answer

Ligand Pharmaceuticals has made the most acquisitions in the Biotechnology sector.

Question 15

In which year did Ligand Pharmaceuticals make the most acquisitions?

Accepted Answer

Ligand Pharmaceuticals made the most acquisitions in 2020, with 4 deals.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Ligand Pharmaceuticals

Company Details

Funding & Financials

IPO & Stock

Web Traffic

Technology & IP

Investor Activity

Company Info

Signals & Scores

Investments by Ligand Pharmaceuticals

Acquisitions by Ligand Pharmaceuticals

Key People at Ligand Pharmaceuticals

Explore 200,000+ acquisitions — free

Recent News related to Ligand Pharmaceuticals

FAQs about Ligand Pharmaceuticals

People who checked this page also checked these